Fred Hutch licenses new immunotherapy treatment to Mustang Bio, preps clinical trials in Seattle A new immunotherapy technology developed at Seattle’s Fred Hutchinson Cancer Research Center has been licensed to New York-based Mustang Bio,… Read More
